Covid was not on the radar when I invested so still believe this drug will be very successful for other patients. People need to keep in mind how it works and all the indications for the medication. Covid has brought a lot of attention to Leronlimab at the FDA and other health organizations which will lead to faster approval in other areas. Staying strong for CYDY.